Orchidia Pharma aims to invest EGP 200 mn to establish a new eyedrops factory in Obour City, Production Manager Mohamed Etman told the local press. The company has agreed to import three production lines, including two of whose production capacity is at 30 mn eye drops per year. The EUR 500k third production line is expected to begin producing about 12 mn eye ointments annually next year, Etman said, adding that the company also plans to set up a fourth line in the future.
More from Enterprise
The digital EGP won’t look different at checkout — but it will work nothing like InstaPay
Every instant payment today depends on your bank or telco.…
Granite is about to test whether Egypt’s funds still need administrators
The asset manager and blockchain builder Tarmiiz have entered the…
Egypt is fixing how deals get executed, but what pushes investors offshore runs deeper than the reforms on the table
Investment Ministry and a Senate committee are both moving to…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…